Health · Medical Research · 7 hrs ago
AI-guided brain stimulation reduced PTSD symptoms in a veteran study
Researchers tested AI-guided brain stimulation for PTSD in a study involving military veterans.
The treatment used noninvasive transcranial magnetic stimulation, or TMS, which stimulates the brain from outside the body.
More than 70 veterans with PTSD took part; 36 received the stimulation and 37 received a placebo treatment.
The researchers said symptoms fell over two weeks with the AI-guided treatment.
PTSD can cause symptoms such as distressing memories, avoidance, sleep problems and difficulty managing emotions, and existing treatments include therapy and medication.
The findings may offer another treatment option for people who have not benefited enough from those approaches.
The study focused on veterans, and the information provided does not say what further research or treatment steps are planned.
An AI-guided, noninvasive brain stimulation treatment reduced PTSD symptoms among military veterans in a study.
The treatment combined machine learning with transcranial magnetic stimulation (TMS).
The study included more than 70 veterans aged 18 to 55 who had been diagnosed with PTSD.
Thirty-six participants were randomly assigned to receive the stimulation, while 37 received a placebo.
The article says the treatment reduced symptoms in two weeks.
- Who
- More than 70 military veterans aged 18 to 55 who had PTSD.
- What
- Researchers studied AI-guided, noninvasive TMS. The article reports reduced PTSD symptoms after two weeks.
- When
- The study appeared in the November-December 2026 edition of Personalized Medicine in Psychiatry. The article was published on November 10, 2026.
- Where
- Not stated.
- Why
- To study a potential treatment for PTSD, including for people who have not benefited from traditional approaches.
This story does not have two clearly opposing sides.
The study appeared in the November-December edition of Personalized Medicine in Psychiatry.
Psychology Today published its article about the study.
- Participants
- More than 70 military veterans
- Age range
- 18 to 55 years
- Stimulation group
- 36 participants
- Placebo group
- 37 participants
- Treatment period
- Two weeks
What people are saying
These findings mark a significant step forward in PTSD therapy, offering a non-pharmacologic treatment for individuals who have not benefited from traditional therapeutic approaches
The results of this study are particularly meaningful in the context of PTSD treatment, where a substantial fraction of patients does not fully respond to existing pharmacologic and psychological therapies